Form 4: Omega Healthcare Investors Director Stephen Plavin Reports Acquisition and Conversion of Profits Interest Units
SEC Form 4 Filing
Director Stephen D. Plavin reports the acquisition and conversion of Profits Interest Units (PIUs) into OP Units and common stock of Omega Healthcare Investors.
Summary
- Stephen D. Plavin, a director of Omega Healthcare Investors, Inc., reported transactions involving Profits Interest Units (PIUs) and OP Units on June 7, 2024.
- Plavin acquired 4,641 PIUs, which are contingent rights to receive OP Units, as part of an annual grant, vesting on the date of the Company's 2025 Annual Meeting of Shareholders.
- He also converted 5,023 vested PIUs into OP Units and subsequently converted 5,023 OP Units into common stock.
- Following these transactions, Plavin beneficially owns 15,204 shares of common stock, 8,610 OP Units, and 13,633 PIUs.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports transactions related to equity compensation.
Positives
- The director's continued holding of OP Units and PIUs demonstrates ongoing alignment with the company's performance.
Future Outlook
The reporting person's PIUs granted on June 7, 2024, will vest on the date of the Company's 2025 Annual Meeting of Shareholders, subject to continued service.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies, and provides transparency regarding the holdings of company directors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect the director's ongoing equity stake in the company.
Key Dates
| Date | Description |
|---|---|
| 2022-02-09 | Date of Power of Attorney execution. |
| 2023-06-05 | Date of previous PIU grant that vested on June 7, 2024. |
| 2024-06-07 | Date of transactions: acquisition of PIUs, conversion of PIUs to OP Units, and conversion of OP Units to common stock. |
| 2024-06-11 | Date of Form 4 filing. |
| 2025 | Vesting date for PIUs granted on June 7, 2024, at the Company's Annual Meeting of Shareholders. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.